A review of patient and carer participation and the use of qualitative research in the development of core outcome sets

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Jones, Janet E ^a   Jones, Laura L ^a   Keeley, Thomas J H ^b   Calvert, Melanie J ^a   Mathers, Jonathan ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b PAREXEL INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXERCISE; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; QUALITATIVE ANALYSIS; QUALITATIVE RESEARCH; CAREGIVER; OUTCOME ASSESSMENT; PATIENT PARTICIPATION;

CAREGIVERS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; QUALITATIVE RESEARCH;

EID: 85015753619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172937     Document Type: Review

References (87)

1. NHS Choices 2015 [updated 10 July 2015]. http://www.nhs.uk/Conditions/Clinical-trials/Pages/ Introduction.aspx.
2. NICE Nationl Institute for Health and Care Excellence [cited 2016 14 June]. https://www.nice.org.uk/.
3. The National Institute for Health Research 2015 [2 April 2015]. http://www.nihr.ac.uk/about/mission-ofthe-nihr.htm.
4. COMET initiative 2011 [cited 2015 26 January]. http://www.comet-initiative.org/.
5. Devane D, Begley CM, Clarke M, Horey D, Oboyle C. Evaluating Maternity Care: A Core Set of Outcome Measures. Birth. 2007; 34(2):164-72. https://doi.org/10.1111/j.1523-536X.2006.00145.x PMID: 17542821
6. Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M, et al. Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review. PLoS One [Internet]. 2014; 9(6):[e99111 p.]. https://doi.org/10.1371/journal.pone.0099111 PMID: 24932522
7. Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials. 2007; 8(1):39.
8. Whitehead L, Perkins G, Clarey A, Haywood K. A systematic review of the outcomes reported in cardiac arrest clinical trials: The need for a core outcome set. Resuscitation. 2015;Article in press.
9. Clarke M, Williamson PR. Core outcome sets and systematic reviews. Sys Rev. 2016; 5(1):1-4.
10. Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13(1):132.
11. Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol. 2003; 30(4):877-9. Epub 2003/04/03. PMID: 12672220
12. Ritchie J, Lewis J, McNaughton Nicolls C, Ormston R, editors. Qualitative Research Practice: a Guide for Social Science Students and Researchers. 2nd ed. ed. London: Sage; 2013.
13. Gargon E, Williamson P, Altman DG, Blazeby J, Clarke M. The COMET Initiative database: progress and activities from 2011 to 2013. Trials. 2014; 15:279. https://doi.org/10.1186/1745-6215-15-279 PMID: 25012001
14. Carter SM, Little M. Justifying Knowledge, Justifying Method, Taking Action: Epistemologies, Methodologies, and Methods in Qualitative Research Qual Health Res. 2007; 17(10):1316-28. https://doi.org/10. 1177/1049732307306927 PMID: 18000071
15. CASP Qualitative Checklist 2013 [5 October 2015]. http://www.casp-uk.net/#!casp-tools-checklists/ c18f8.
16. Allard A, Fellowes A, Shilling V, Janssens A, Beresford B, Morris C. Key health outcomes for children and young people with neurodisability: qualitative research with young people and parents. BMJ Open. 2014; 4(4):e004611. Epub 2014/04/22. https://doi.org/10.1136/bmjopen-2013-004611 PMID: 24747792
17. Janssens A, Williams J, Tomlinson R, Logan S, Morris C. Health outcomes for children with neurodisability: what do professionals regard as primary targets? Archives of disease in childhood. 2014; 99 (10):927-32. Epub 2014/05/24. https://doi.org/10.1136/archdischild-2013-305803 PMID: 24854564
18. MacKichan F, Wylde V, Gooberman-Hill R. Pathways Through Care for Long-Term Pain after Knee Replacement: A Qualitative Study of Healthcare Professionals. Musculoskeletal Care. 2015.
19. Potter S, Mills N, Cawthorn S, Wilson S, Blazeby J. Exploring inequalities in access to care and the provision of choice to women seeking breast reconstruction surgery: a qualitative study. British journal of cancer. 2013; 109(5):1181-91. Epub 2013/08/10. https://doi.org/10.1038/bjc.2013.461 PMID: 23928662
20. Potter S, Mills N, Cawthorn SJ, Donovan J, Blazeby JM. Time to be BRAVE: is educating surgeons the key to unlocking the potential of randomised clinical trials in surgery? A qualitative study. Trials. 2014; 15:80. Epub 2014/03/19. https://doi.org/10.1186/1745-6215-15-80 PMID: 24628821
21. Stamm T, van der Giesen F, Thorstensson C, Steen E, Birrell F, Bauernfeind B, et al. Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: a qualitative European multicentre study. Ann Rheum Dis. 2009; 68(9):1453-60. Epub 2008/09/04. https://doi. org/10.1136/ard.2008.096776 PMID: 18765429
22. Swigris JJ, Stewart AL, Gould MK, Wilson SR. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health and quality of life outcomes. 2005; 3:61. Epub 2005/10/11. https://doi.org/10.1186/1477-7525-3-61 PMID: 16212668
23. Morris C, Janssens A, Shilling V, Allard A, Fellowes A, Tomlinson R, et al. Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures. Health and quality of life outcomes. 2015; 13:87. Epub 2015/06/26. https://doi.org/10. 1186/s12955-015-0284-7 PMID: 26108625
24. Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of fibromyalgia. Patient Edu Couns. 2008; 73(1):114-20. http://dx.doi.org/10.1016/j.pec.2008. 06.005.
25. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises. Arthritis Care Res. 2008; 59(7):952-60.
26. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol. 2007; 34(6):1415-25. PMID: 17552068
27. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, et al. Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct. J Rheumatol. 2009; 36(10):2318-29. https://doi.org/10.3899/ jrheum.090367 PMID: 19820221
28. Kloppenburg M, Boyesen P, Smeets W, Haugen IK, Liu R, Visser W, et al. Report from the OMERACT Hand Osteoarthritis Special Interest Group: advances and future research priorities. J Rheumatol. 2014; 41(4):810-8. Epub 2014/01/17. https://doi.org/10.3899/jrheum.131253 PMID: 24429165
29. Potter S, Holcombe C, Ward JA, Blazeby JM. Development of a core outcome set for research and audit studies in reconstructive breast surgery. The British journal of surgery. 2015. Epub 2015/07/17.
30. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res. 2010a; 62(5):640-6.
31. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: The rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res. 2010b; 62(5):647-56.
32. Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, et al. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases. J Rheumatol. 2014a; 41(4):792-8. Epub 2014/02/ 04.
33. Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, et al. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax. 2014b; 69(5):428-36. Epub 2013/12/26.
34. Tierney S, O'Brien K, Harman NL, Madden C, Sharma RK, Callery P. Risks and benefits of ventilation tubes and hearing aids from the perspective of parents of children with cleft palate. International journal of pediatric otorhinolaryngology. 2013; 77(10):1742-8. Epub 2013/09/07. https://doi.org/10.1016/j. ijporl.2013.08.006 PMID: 24007893
35. Tierney SP, O'Brien KP, Harman NLP, Sharma RKF, Madden CMD, Callery PP. Otitis Media With Effusion: Experiences of Children With Cleft Palate and Their Parents. Cleft Palate Craniofac J. 2015; 52 (1):23-30. https://doi.org/10.1597/13-139 PMID: 24237229
36. Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O'Brien K, et al. The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate. PLoS One. 2015; 10(6):e0129514. Epub 2015/06/27. https://doi.org/10.1371/journal.pone. 0129514 PMID: 26115172
37. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, et al. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain. 2008; 137(2):276-85. http://dx.doi.org/10.1016/j.pain.2007.09.002. PMID: 17937976
38. Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, et al. Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board. Cancer Invest. 2002; 20(5-6):793-800. PMID: 12197238
39. Bennett WL, Robinson KA, Saldanha IJ, Wilson LM, Nicholson WK. High Priority Research Needs for Gestational Diabetes Mellitus. J Womens Health. 2012; 21(9):925-32.
40. Broder MS, Landow WJ, Goodwin SC, Brook RH, Sherbourne CD, Harris K. An Agenda for Research into Uterine Artery Embolization: Results of an Expert Panel Conference. J Vasc Interv Radiol. 2000; 11(4):509-15. http://dx.doi.org/10.1016/S1051-0443(07)61386-4. PMID: 10787212
41. Buch MH, Silva-Fernandez L, Carmona L, Aletaha D, Christensen R, Combe B, et al. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology. Ann Rheum Dis. 2015; 74(6):963-9. Epub 2014/05/16. https://doi.org/10.1136/annrheumdis-2013-204948 PMID: 24827533
42. Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, et al. Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder: Report of a Consensus Conference. J Child Adolesc Psychopharmacol. 2003; 13(1):13-27. http://dx.doi.org/10. 1089/104454603321666162. PMID: 12804123
43. Chiarotto A, Deyo RA, Terwee CB, Boers M, Buchbinder R, Corbin TP, et al. Core outcome domains for clinical trials in non-specific low back pain. Eur Spine J. 2015; 24(6):1127-42. Epub 2015/04/07. https:// doi.org/10.1007/s00586-015-3892-3 PMID: 25841358
44. Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, et al. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler. 2012; 18(1):116-27. https://doi.org/10.1177/1352458511430704 PMID: 22146610
45. Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, et al. International Pediatric MS Study Group Clinical Trials Summit: Meeting report. Neurology. 2013; 80(12):1161-8. https://doi.org/10.1212/ WNL.0b013e318288694e PMID: 23509048
46. Gladman DD. Consensus exercise on domains in psoriatic arthritis. Ann Rheum Dis. 2005; 64(suppl 2): ii113-ii4.
47. Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol. 2007; 34(5):1167-70. PMID: 17477480
48. Goldhahn J, Beaton D, Ladd A, Macdermid J, Hoang-Kim A. Recommendation for measuring clinical outcome in distal radius fractures: a core set of domains for standardized reporting in clinical practice and research. Archives of orthopaedic and trauma surgery. 2014; 134(2):197-205. Epub 2013/06/04. https://doi.org/10.1007/s00402-013-1767-9 PMID: 23728832
49. Gonz ález U, Whitton M, Eleftheriadou V, Pinart M, Batchelor J, Leonardi-Bee J. Guidelines for designing and reporting clinical trials in vitiligo. Arch Dermatol. 2011; 147(12):1428-36. https://doi.org/10. 1001/archdermatol.2011.235 PMID: 21844427
50. Eleftheriadou V, Thomas KS, Whitton ME, Batchelor JM, Ravenscroft JC. Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials. The British journal of dermatology. 2012; 167(4):804-14. https://doi.org/10.1111/ j.1365-2133.2012.11056.x PMID: 22591025
51. Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, et al. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res. 2015; 28 (3):363-9. Epub 2015/02/04. https://doi.org/10.1111/pcmr.12354 PMID: 25645179
52. Haeusler GM, Phillips RS, Lehrnbecher T, Thursky KA, Sung L, Ammann RA. Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel. Pediatric blood & cancer. 2015; 62(3):483-9. Epub 2014/12/03.
53. Haywood KL, Griffin XL, Achten J, Costa ML. Developing a core outcome set for hip fracture trials. Bone Joint J. 2014; 96-B(8):1016-23. https://doi.org/10.1302/0301-620X.96B8.33766 PMID: 25086115
54. Karas J, Ashkenazi S, Guarino A, Lo Vecchio A, Shamir R, Vandenplas Y, et al. A core outcome set for clinical trials in acute diarrhoea. Archives of disease in childhood. 2015; 100(4):359-63. Epub 2014/11/ 22. https://doi.org/10.1136/archdischild-2014-307403 PMID: 25414251
55. Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr. 2007; 19(03):345-54.
56. Merkies ISJ, Lauria G. 131st ENMC International workshop: Selection of Outcome Measures for Peripheral Neuropathy Clinical Trials: 10-12 December 2004, Naarden, The Netherlands. Neuromuscul Dis. 2006; 16(2):149-56. http://dx.doi.org/10.1016/j.nmd.2005.12.003.
57. Moniz-Cook E, Vernooij-Dassen M, Woods R, Verhey F, Chattat R, Vugt MD, et al. A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health. 2008; 12(1):14-29. https://doi.org/10.1080/13607860801919850 PMID: 18297476
58. Reilly MM, de Jonghe P, Pareyson D. 136th ENMC International Workshop: Charcot-Marie-Tooth Disease Type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands. Neuromuscular disorders: NMD. 2006; 16(6):396-402. http://dx.doi.org/10.1016/j.nmd.2006.03.008. PMID: 16684603
59. Salaffi F, Ciapetti A, Sarzi Puttini P, Atzeni F, Iannuccelli C, Di Franco M, et al. Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience. Reumatismo. 2012; 64(1).
60. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy and Clin Immunol. 2007; 120(6):1389-98. http://dx.doi.org/10.1016/j.jaci. 2007.08.011.
61. Schmitt J, Williams H. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), July 2010, Munich, Germany. The British journal of dermatology. 2010; 163(6):1166-8. PMID: 21137114
62. Schmitt J, Langan S, Stamm T, Williams HC. Core Outcome Domains for Controlled Trials and Clinical Recordkeeping in Eczema: International Multiperspective Delphi Consensus Process. J Invest Dermatol. 2011; 131(3):623-30. http://www.nature.com/jid/journal/v131/n3/suppinfo/jid2010303s1.html. https://doi.org/10.1038/jid.2010.303 PMID: 20944653
63. Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012; 67 (9):1111-7. https://doi.org/10.1111/j.1398-9995.2012.02874.x PMID: 22844983
64. Sinha IP, Gallagher R, Williamson P, Smyth R. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012; 13(1):103.
65. Stuart GCE, Kitchener H, Bacon M, duBois A, Friedlander M, Lederman J, et al. 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer. Int J Gynecol Cancer. 2011; 21(4):750-5. https://doi.org/10.1097/IGC.0b013e31821b2568 PMID: 21543936
66. Thigpen T, DuBois A, McAlpine J, DiSaia P, Fujiwara K, Hoskins W, et al. First-Line Therapy in Ovarian Cancer Trials. Int J Gynecol Cancer. 2011; 21:756-62. https://doi.org/10.1097/IGC. 0b013e31821ce75d PMID: 21543937
67. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT committee. J Rheumatol. 1993; 20(3):555-6. PMID: 8478872
68. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmèn M, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol. 2003; 30(4):868-72. PMID: 12672218
69. Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis-progress at OMERACT 7. J Rheumatol. 2005; 32(11):2250-6. PMID: 16265712
70. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol. 2007; 34 (5):1174-7. PMID: 17477482
71. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol. 1997; 24(11):2225-9. PMID: 9375888
72. Vargus-Adams JN, Martin LK. Measuring What Matters in Cerebral Palsy: A Breadth of Important Domains and Outcome Measures. Arch Phys Med Rehabil. 2009; 90(12):2089-95. http://dx.doi.org/10. 1016/j.apmr.2009.06.018. PMID: 19969173
73. Wylde V, MacKichan F, Bruce J, Gooberman-Hill R. Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set. European journal of pain (London, England). 2015; 19(5):611-20. Epub 2014/08/27.
74. Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. The use of triangulation in qualitative research. Oncol Nurs Forum. 2014; 41(5):545-7. Epub 2014/08/28. https://doi.org/10.1188/14.ONF. 545-547 PMID: 25158659
75. Duffy JMN, van 't Hooft J, Gale C, Brown M, Grobman W, Fitzpatrick R, et al. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. Pregnancy Hypertens. http:// dx.doi.org/10.1016/j.preghy.2016.04.008.
76. Kaiser U, Kopkow C, Deckert S, Sabatowski R, Schmitt J. Validation and application of a core set of patient-relevant outcome domains to assess the effectiveness of multimodal pain therapy (VAPAIN): a study protocol. BMJ Open. 2015; 5(11):e008146. Epub 2015/11/08. https://doi.org/10.1136/bmjopen-2015-008146 PMID: 26547084
77. Keeley T, Khan H, Pinfold V, Williamson P, Mathers J, Davies L, et al. Core outcome sets for use in effectiveness trials involving people with bipolar and schizophrenia in a community-based setting (PARTNERS2): study protocol for the development of two core outcome sets. Trials. 2015; 16(1):47. Epub 2015/04/19.
78. MacLennan S, Bekema HJ, Williamson PR, Campbell MK, Stewart F, MacLennan SJ, et al. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey. Trials. 2015; 16(1):76. Epub 2015/04/19.
79. Waters AM, Tudur Smith C, Young B, Jones TM. The CONSENSUS study: protocol for a mixed methods study to establish which outcomes should be included in a core outcome set for oropharyngeal cancer. Trials. 2014; 15:168. Epub 2014/06/03. https://doi.org/10.1186/1745-6215-15-168 PMID: 24885068
80. Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey. PLoS ONE. 2016; 11(1):e0146444. https://doi.org/10.1371/journal.pone.0146444 PMID: 26785121
81. Young B, Bagley H. Including patients in core outcome set development: issues to consider based on three workshops with around 100 international delegates. Research Involvement and Engagement. 2016; 2(1):1-13.
82. Caelli K, Ray L, Mill J. 'Clear as Mud': Toward greater clarity in generic qualitative research. Int J Qual Methods. 2003; 2(2):1-24.
83. Kahlke R. Generic qualitative approaches: pitfalls and benefits of methodological mixology. Int J Qual Methods 2014; 13:37-52.
84. Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010; 19(8):1087-96. Epub 2010/06/01. https://doi.org/10.1007/s11136-010-9677-6 PMID: 20512662
85. Keeley T, Williamson P, Callery P, Jones LL, Mathers J, Jones J, et al. The use of qualitative methods to inform Delphi surveys in core outcome set development. Trials. 2016; 17(1):1-9.
86. Sanderson T, Hewlett S, Calnan M, Morris M, Raza K, Kumar K. Exploring the cultural validity of rheumatology outcomes. Br J Nurs. 2012; 21(17):1015-20, 522-3. Epub 2012/11/06. https://doi.org/10. 12968/bjon.2012.21.17.1015 PMID: 23123747
87. Mathers J, Keeley T, Jones L, Calvert M, Williamson P, Jones J, et al. Using qualitative research to understand what outcomes matter to patients: direct and indirect approaches to outcome elicitation. Trials. 2015; 16(2):1-.